Darya-Varia Laboratoria Tbk (DVLA) - Total Liabilities
Based on the latest financial reports, Darya-Varia Laboratoria Tbk (DVLA) has total liabilities worth Rp904.97 Billion IDR (≈ $53.03 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore DVLA operating cash flow to assess how effectively this company generates cash.
Darya-Varia Laboratoria Tbk - Total Liabilities Trend (2000–2024)
This chart illustrates how Darya-Varia Laboratoria Tbk's total liabilities have evolved over time, based on quarterly financial data. Check Darya-Varia Laboratoria Tbk (DVLA) asset resilience to evaluate the company's liquid asset resilience ratio.
Darya-Varia Laboratoria Tbk Competitors by Total Liabilities
The table below lists competitors of Darya-Varia Laboratoria Tbk ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Frontier Energy Ltd
AU:FHE
|
Australia | AU$855.45K |
|
Americas Car-Mart Inc
NASDAQ:CRMT
|
USA | $1.16 Billion |
|
Hurriyet Gazetecilik ve Matbaacilik AS
IS:HURGZ
|
Turkey | TL2.59 Billion |
|
Hanil Feed Co. Ltd
KQ:005860
|
Korea | ₩61.24 Billion |
|
Netfonds AG
XETRA:NF4
|
Germany | €83.24 Million |
|
Geodrill Ltd
F:7GD
|
Germany | €49.18 Million |
|
AleAnna, Inc. Class A Common Stock
NASDAQ:ANNA
|
USA | $41.73 Million |
|
Clarus Corp
NASDAQ:CLAR
|
USA | $57.27 Million |
Liability Composition Analysis (2000–2024)
This chart breaks down Darya-Varia Laboratoria Tbk's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Darya-Varia Laboratoria Tbk (DVLA) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.37 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.61 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Darya-Varia Laboratoria Tbk's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Darya-Varia Laboratoria Tbk (2000–2024)
The table below shows the annual total liabilities of Darya-Varia Laboratoria Tbk from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Rp712.57 Billion ≈ $41.75 Million |
+11.73% |
| 2023-12-31 | Rp637.74 Billion ≈ $37.37 Million |
+5.32% |
| 2022-12-31 | Rp605.52 Billion ≈ $35.48 Million |
-14.12% |
| 2021-12-31 | Rp705.11 Billion ≈ $41.32 Million |
+6.77% |
| 2020-12-31 | Rp660.42 Billion ≈ $38.70 Million |
+26.06% |
| 2019-12-31 | Rp523.88 Billion ≈ $30.70 Million |
+8.56% |
| 2018-12-31 | Rp482.56 Billion ≈ $28.28 Million |
-8.01% |
| 2017-12-31 | Rp524.59 Billion ≈ $30.74 Million |
+16.11% |
| 2016-12-31 | Rp451.79 Billion ≈ $26.47 Million |
+12.17% |
| 2015-12-31 | Rp402.76 Billion ≈ $23.60 Million |
+47.09% |
| 2014-12-31 | Rp273.82 Billion ≈ $16.04 Million |
-0.56% |
| 2013-12-31 | Rp275.35 Billion ≈ $16.13 Million |
+18.10% |
| 2012-12-31 | Rp233.14 Billion ≈ $13.66 Million |
+16.36% |
| 2011-12-31 | Rp200.37 Billion ≈ $11.74 Million |
-6.15% |
| 2010-12-31 | Rp213.51 Billion ≈ $12.51 Million |
-6.64% |
| 2009-12-31 | Rp228.69 Billion ≈ $13.40 Million |
+76.17% |
| 2008-12-31 | Rp129.81 Billion ≈ $7.61 Million |
+31.52% |
| 2007-12-31 | Rp98.70 Billion ≈ $5.78 Million |
-31.94% |
| 2006-12-31 | Rp145.03 Billion ≈ $8.50 Million |
-9.37% |
| 2005-12-31 | Rp160.03 Billion ≈ $9.38 Million |
+42.69% |
| 2004-12-31 | Rp112.15 Billion ≈ $6.57 Million |
+12.06% |
| 2003-12-31 | Rp100.08 Billion ≈ $5.86 Million |
+4.43% |
| 2002-12-31 | Rp95.84 Billion ≈ $5.62 Million |
-55.81% |
| 2001-12-31 | Rp216.89 Billion ≈ $12.71 Million |
+5.23% |
| 2000-12-31 | Rp206.10 Billion ≈ $12.08 Million |
-- |
About Darya-Varia Laboratoria Tbk
PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company offers prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women hea… Read more